We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,822
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Berkshire Hathaway Class B
BRK.B
$1.12T
| $53.3M | 0.28% |
195,297
+47,998
| +33% | +$13.5M |
|
77
Merck
MRK
$316B
| $53M | 0.28% |
705,517
+17,426
| +3% | +$1.33M |
|
78
Bristol-Myers Squibb
BMY
$135B
| $52.9M | 0.28% |
893,359
+56,007
| +7% | +$3.69M |
|
|
79
Regeneron Pharmaceuticals
REGN
$78.3B
| $52.9M | 0.28% |
87,334
-102,416
| -54% | -$63.6M |
|
|
NEWR
80
DELISTED
New Relic, Inc.
NEWR
| $52.7M | 0.28% |
733,673
+10,352
| +1% | +$765K |
|
81
Kohl's
KSS
$2.28B
| $51.6M | 0.27% |
1,095,865
-197,669
| -15% | -$10.6M |
|
82
Procter & Gamble
PG
$345B
| $51.2M | 0.27% |
366,089
+39,038
| +12% | +$5.53M |
|
83
Trimble
TRMB
$13.9B
| $51.1M | 0.27% |
620,897
+10,122
| +2% | +$889K |
|
84
iShares Core S&P Small-Cap ETF
IJR
$113B
| $51M | 0.27% |
466,700
+111,087
| +31% | +$12.2M |
|
85
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34B
| $50M | 0.26% |
1,065,820
+483,075
| +83% | +$23.4M |
|
86
First Solar
FSLR
$26.2B
| $50M | 0.26% |
523,391
+19,824
| +4% | +$1.84M |
|
87
ExxonMobil
XOM
$638B
| $49.8M | 0.26% |
846,901
+18,511
| +2% | +$1.05M |
|
88
Tesla
TSLA
$1.29T
| $48.2M | 0.25% |
186,582
+7,644
| +4% | +$1.8M |
|
89
Pfizer
PFE
$145B
| $48.2M | 0.25% |
1,121,322
+141,066
| +14% | +$6.25M |
|
90
Omnicell
OMCL
$1.69B
| $47.7M | 0.25% |
321,097
-933
| -0.3% | -$143K |
|
91
Walmart Inc
WMT
$888B
| $47.5M | 0.25% |
1,022,775
+129,765
| +15% | +$6.25M |
|
92
State Street Technology Select Sector SPDR ETF
XLK
$123B
| $47.3M | 0.25% |
633,540
+257,174
| +68% | +$19.8M |
|
93
iShares Russell 2000 ETF
IWM
$83B
| $47.1M | 0.25% |
215,179
+34,641
| +19% | +$7.68M |
|
94
Accenture
ACN
$104B
| $46.7M | 0.25% |
145,932
+15,560
| +12% | +$5.06M |
|
95
Blackstone
BX
$110B
| $46.4M | 0.24% |
398,752
+70,493
| +21% | +$8.18M |
|
96
Eaton
ETN
$173B
| $46.1M | 0.24% |
308,612
+6,655
| +2% | +$1.06M |
|
97
State Street Financial Select Sector SPDR ETF
XLF
$58.5B
| $45.8M | 0.24% |
1,221,234
+131,036
| +12% | +$4.9M |
|
98
CVS Health
CVS
$133B
| $45.6M | 0.24% |
537,708
+86,624
| +19% | +$7.26M |
|
99
Prologis
PLD
$130B
| $45M | 0.24% |
358,829
+35,480
| +11% | +$4.6M |
|
100
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.4B
| $44.9M | 0.24% |
459,093
+215,084
| +88% | +$21.7M |
|
Similar funds
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,822 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.